Healthcare - Articles

Biologics CDMO Market, By Type (Mammalian, Non-Mammalian), By Product Type (Biologics (Recombinant Proteins, Vaccines, Monoclonal, Antisense & Molecular Therapy, and Other Biologics) and Biosimilars)
Introduction In recent years, the biologics market has witnessed exponential growth, driven by the increasing demand for biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Central to this surge is the pivotal role played by Contract Development and Manufacturing Organizations (CDMOs). These specialized service providers are integral to the biopharmaceutical industry, offering comprehensive support from early-stage development to large-scale commercial production. This article delves into the current trends, challenges, and future prospects of the Biologics CDMO M…

The Global Hormone Replacement Therapy Market Size accounted for USD 21.6 Billion in 2022 and is projected to achieve a market size of of USD 39.8 Billion by 2032 growing at a CAGR of 6.4% from 2023 to 2032.
According to Acumen Research and Consulting, The Global Hormone Replacement Therapy Market Size accounted for USD 21.6 Billion in 2022 and is projected to achieve a market size of of USD 39.8 Billion by 2032 growing at a CAGR of 6.4% from 2023 to 2032. Hormone Replacement Therapy (HRT) has emerged as a critical component in the management of hormonal imbalances, particularly for menopause-related symptoms in women. As the global population ages and awareness around hormonal health grows, the HRT market is experiencing significant evolution. This article explores the competitiv…

With more than seven million patients on waiting lists and over 90,000 people still experiencing 65-week wait times, linking patient data continues to be a critical goal for the overburdened NHS of today. When addressing patient queries, outpatient care centre agents frequently struggle with many systems, manual procedures and fragmented data. For the patient, this results in extended waiting times, high number of repeat calls, and increased anxiety waiting for a response.
With more than seven million patients on waiting lists and over 90,000 people still experiencing 65-week wait times, linking patient data continues to be a critical goal for the overburdened NHS of today. When addressing patient queries, outpatient care centre agents frequently struggle with many systems, manual procedure…

The digital therapeutics (DTx) industry aims to introduce new and innovative approaches to healthcare delivery through technology. Because of its novelty, many companies in this space are unfamiliar with the steps necessary to bring a new digital intervention to market – a process that can take several years. Thus, being intentional with the way they interact with the FDA can save DTx companies time and make their journeys less arduous.
The digital therapeutics (DTx) industry aims to introduce new and innovative approaches to healthcare delivery through technology. Because of its novelty, many companies in this space are unfamiliar with the steps necessary to bring a new digital intervention to market – a process that can take several years. Thus, being intentional with the way they interac…

Pharma franchise companies offer a business model where pharmaceutical companies grant individuals or entities the rights to market and sell their products under the company’s brand name. These companies provide a ready-made platform with an established brand, product portfolio, and marketing support, reducing the risk for franchisees. The franchisee benefits from the parent company's research, development, and regulatory approvals, while focusing on sales and distribution in specific regions. This model is cost-effective, as it eliminates the need for manufacturing, and allows quick entry into the pharmaceutical market with lower investment and operational overheads.
The pharmaceutical industry has been experiencing a paradigm shift with the emergence and growth of pharma franchise compani…

Snap research by digital insights consultancy Creation Healthcare has revealed that online healthcare professionals shared and discussed news that a shingles vaccine has been linked with delaying the onset of dementia more than 72 hours before it was first reported in national media.
Online healthcare professionals were more than 72 hours ahead of mainstream media in sharing the news of a seismic study linking Shingrix, a shingles vaccine, to the delayed onset of dementia in patients. That is according to new investigative research by Creation Healthcare, who analysed the social media conversations of healthcare professionals discussing shingles vaccines immediately after the news broke in major media outlets on Thursday afternoon, 25th July. Their study found that healthcare professionals…

The global demand for Augmented Reality (AR) and Virtual Reality (VR) in the healthcare market is projected to experience substantial growth, reaching an estimated market size of approximately USD 18.02 billion by 2032, up from USD 3.67 billion in 2023.
The global Augmented Reality (AR) and Virtual Reality (VR) in healthcare market is anticipated to grow significantly, with projections indicating a rise from USD 3.67 billion in 2023 to nearly USD 18.02 billion by 2032. This remarkable increase represents a robust compound annual growth rate (CAGR) of 19.33% over the forecast period from 2024 to 2032. The rapid expansion of the market is driven by the increasing adoption of AR and VR technologies for various applications, including enhanced medical training, advanced surgical simulations…

Research conducted by Pioneer Group sheds light on the current investment trends shaping the life sciences landscape, offering insights into where capital is being allocated and what it means for the sector.
Research conducted by Pioneer Group sheds light on the current investment trends shaping the life sciences landscape, offering insights into where capital is being allocated and what it means for the sector. The fall in venture capital investment levels over recent years has caused some concern in the real estate sector. However, it’s important to note that 2021 witnessed a whirlwind of venture capital activity, particularly in the first and second quarters. These periods were marked by a handful of colossal investments, including landmark figures pumped into entities like CMR Surgical…

The healthcare landscape is in the process of being dramatically transformed by the advent of digital health technology, driving innovation and revolutionizing healthcare delivery. Artificial Intelligence (AI) and Machine Learning (ML) are particularly poised to impact several healthcare domains, from diagnostics and treatment to patient monitoring and management.
The healthcare landscape is in the process of being dramatically transformed by the advent of digital health technology, driving innovation and revolutionizing healthcare delivery. Artificial Intelligence (AI) and Machine Learning (ML) are particularly poised to impact several healthcare domains, from diagnostics and treatment to patient monitoring and management. These technologies hold significant promise, especially in underfun…

Inpatient services refer to medical treatments and care that require a patient to be admitted to a hospital or healthcare facility for at least one night. These services encompass a wide range of medical care, including surgeries, childbirth, severe illnesses, and chronic disease management. Inpatient services are a critical component of the healthcare system, ensuring patients receive comprehensive care and monitoring when outpatient services are insufficient. The rising incidence of chronic diseases such as diabetes, cardiovascular diseases, and cancer has significantly contributed to the growth of the inpatient services market. As these conditions often require complex and prolonged treatments, the demand for inpatient services has surged, leading to the expansion of healthcare facilities and the adoption of advanced medical technologies.

We are delighted to announce that the second edition of our popular introductory guide: ‘Market access stakeholders and processes for medical devices in key European markets’ is now available. Our market access experts have updated the guide with European market insights for 2024/25, along with a new section covering the US market.
An introductory guide to market access stakeholders and processes for medical devices in key European markets and the USA In this introductory guide, our Global market access experts provide an overview of the commercial launch landscape for medical devices in the USA and key European healthcare systems. We highlight the differences between selected markets and provide a go-to guide for those looking to bring medical device innovations to the…

Calum Jones (Associate Director – Health Economics) shares his experience of speaking at the 2024 HTAi Annual Meeting. Calum participated in the panel discussion: ‘Surrogate Endpoints in Health Technology Assessment (HTA): From Trials to Economic Evaluations
  Calum Jones (Associate Director – Health Economics) shares his experience of speaking at the 2024 HTAi Annual Meeting. Calum participated in the panel discussion: ‘Surrogate Endpoints in Health Technology Assessment (HTA): From Trials to Economic Evaluations’. On 18th June, I had the distinct pleasure of participating in an expert panel at the HTAi annual meeting held in the picturesque city of Seville, Spain. The session, titled ‘Surrogate Endpoints in Health Technology Assessment (HTA): From Trials to Economi…

Mtech Access are now part of Petauri. This marks a significant and exciting milestone in our journey, and aligns with our commitment to partnering with industry to bring life-enhancing technologies to market, providing more patient choice and meeting the needs of the healthcare environment.
What this means for our clients: Enhanced services: This strategic move will allow us to offer greater breadth and depth of technical and consulting experience, as well as market coverage for our clients. Continuity and stability: The quality of work and client service that you have come to expect, along with your current projects and relationships, will remain unchanged. Innovative solutions: Leveraging the strengths of the Petauri group, we will build on our commitment to growth and inn…

Global vascular patches market is projected to witness a CAGR of 6.97% during the forecast period 2024–2031F
Global vascular patches market is projected to witness a CAGR of 6.97% during the forecast period 2024–2031F, growing from USD 507.68 million in 2023 to USD 870.12 million in 2031F. The market has experienced significant growth in recent years and is expected to maintain a strong pace of expansion in the coming years. Vascular patches are used to treat aneurysms, arterial stenosis, and undesirable blood clots, in addition to reconstructing tissue or arteries in cardiovascular illnesses. Heart arteries (coronary arterial bypass), kidneys, legs (femoropopliteal bypass), and the abdominal aorta are the usual surgical sites. The increasing global prevalence of cardiovascular disorders is…

In a snap analysis of the social media conversations of healthcare professionals following the news that the NHS has launched its world-first personalised cancer vaccination programme, Creation Healthcare found that, while the response was overwhelmingly positive, some apprehension remained that vaccine hesitancy and anti-vax sentiment could hinder uptake among patients.
Healthcare professionals across the globe have reacted “overwhelmingly positively” to news that thousands of NHS patients in England will be fast-tracked onto a world-first personalised cancer vaccine scheme.  In a snap analysis following the breaking news, leading digital insights consultancy Creation Healthcare found that online healthcare professionals heralded the vaccine as a “game changer”, although som…

Babies who cannot access breast milk are one step closer to benefitting from a pioneering microbiome supplement that will provide them with the crucial microbes required for healthy development.
That’s after the healthcare startup BoobyBiome collaborated with technology innovation centre, CPI. to scale-up their cutting-edge bacterial supplement.  The organisations have announced that the collaboration has brought the supplement closer to commercial reality.  The supplement contains live bacteria identified and sourced from the microbiomes of donated breast milk that can boost the immune systems of babies whose mothers cannot breastfeed.  The product can be added to formula milk, or breast milk for babies who require additional support to improve gut health and develop their…

Explore the comprehensive guide to Whole Slide Imaging scanners, covering benefits, applications, and technology. Read the blog to know more.
 Whole Slide Imaging: Whole slide imaging, commonly known as virtual microscopy, revolutionizes the way pathology specimens are analyzed by digitizing entire tissue slides for comprehensive examination. This technology involves scanning various whole slides digitally in high resolution, stitching together images derived from each field of view across the complete microscopy slide using specialized software. The result is a single digital image file that can be stored safely for archiving and documentation, benefiting the consulting and teaching industries. This cutting-edge technology allows pathologists to view high-resolution images of entire t…

Hannah Palin (Director – Market Access) and Calum Jones (Associate Director – Health Economics) explore the landscape for economic evaluation in the US. They highlight important considerations for companies seeking to infiltrate this key market.
Health economic modelling is fundamental to market access, in both health technology assessment (HTA) and pre and post-launch engagement. It is of value globally, but holds particular importance in markets across Europe, the UK, and Canada, among others. Its application in the US, however, is less established. With a dedicated Health Economics Team, economic modelling is a key area in which Mtech Access support clients. Whilst there are variations in the approaches between HTA markets, we can see commonalities in the requirement for e…

Two senior leaders at Johnson & Johnson (J&), Dr Tamara Werner-Kiechle, Therapeutic Area Lead for Neuroscience, PH & CVM in Europe, Middle East and Africa (EMEA), along with Berkin Gökbudak, Senior Director Commercial Strategy for Neuroscience, PH & CVM in Europe, Middle East and Africa (EMEA), discuss the theme for the 2024 European Psychiatric Congress (EPA) – ‘Mental Health: Open & Inclusive’.
The following article first appeared on the LinkedIn channel of Dr Tamara Werner-Kiechle, Therapeutic Area Lead for Neuroscience, PH & CVM in Europe, Middle East and Africa (EMEA), Johnson & Johnson. This article has been repurposed for publication on Pharmiweb. Two senior leaders at Johnson & Johnson (J&), Dr Tamara Werner-Kiechle, Therapeutic Area Lead for Neuroscience, PH &…

In 2024, the intersection of artificial intelligence (AI) and life sciences is revolutionizing healthcare delivery and patient outcomes. The integration of AI in life sciences has become an indispensable tool for medical professionals, researchers, patients, and other stakeholders as technological advancements continue to unfold rapidly.
In 2024, the intersection of artificial intelligence (AI) and life sciences is revolutionizing healthcare delivery and patient outcomes. The integration of AI in life sciences has become an indispensable tool for medical professionals, researchers, patients, and other stakeholders as technological advancements continue to unfold rapidly. AI is reshaping how people approach healthcare, from drug discovery and precision medicine to clinical decision support…